Study of Glasdegib with Intensive or Standard Chemotherapy in Patients with Untreated Acute Myeloid Leukemia
Study of Glasdegib with Intensive or Standard Chemotherapy in Patients with Untreated Acute Myeloid
Leukemia. A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients With Previously Untreated Acute Myeloid Leukemia.
Category & Conditions: Cancer
Medicine: DAURISMO TABLETS(GLASDEGIB)
ClinicalTrials.gov Identifier (NCT): NCT03416179
Protocol ID: B1371019
PrintDownloadOpen Plain Language Summary Result: Click here